A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias

American Journal of Hematology
Maria Cecilia GoldanigaLuca Baldini

Abstract

CD5-negative chronic B cell lymphoproliferative disorders in leukemic phase (B-CLPD) are heterogeneous and relatively uncommon pathologies that often lack a histopathological definition because of the absence of accessible pathological tissue. We describe the clinical features and evolution-related variables of 156 patients with CD5/CD10-negative B-CLPD (median age 66 years, range 25-86). The median follow-up was 51 months (range 6-216), and overall 3- and 5-year survival was respectively 87 and 76%; 50 patients needed therapy at diagnosis, 56 during follow-up, and 50 remained untreated until the last control. A combined clinical, histological, cytomorphological, immunophenotypical, and cytogenetic diagnostic approach allowed the complete classification of only a minority of patients as being affected by splenic marginal zone or lymphoplasmacytic lymphoma; the majority of cases remained unclassifiable. Multivariate analysis showed that the clinicohematological variables adversely related to overall survival were serum LDH levels and age, whereas high serum LDH levels, hemoglobin levels of <11 g/dl, and splenomegaly related to treatment-free time (in "wait and see" cases); only splenomegaly related to time to progression (in tre...Continue Reading

References

Dec 1, 1992·Statistics in Medicine·W Sauerbrei, M Schumacher
Feb 1, 1995·Leukemia & Lymphoma·F Salomon-NguyenG Flandrin
Jan 23, 1999·American Journal of Clinical Pathology·J C HuangL C Peterson
Nov 30, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N L HarrisC D Bloomfield
Feb 9, 2002·American Journal of Hematology·Chen WangBernard Fernandes
Feb 24, 2006·Blood·Luca ArcainiUNKNOWN Integruppo Italiano Linfomi
Oct 31, 2006·Leukemia & Lymphoma·Clive S Zent
Oct 31, 2006·Leukemia & Lymphoma·Valérie UgoXavier Troussard

❮ Previous
Next ❯

Citations

Jul 16, 2011·Leukemia & Lymphoma·Christopher S MulliganStephen P Mulligan
Oct 16, 2015·British Journal of Cancer·Wahyu WulaningsihMieke Van Hemelrijck
Jan 10, 2009·International Journal of Cancer. Journal International Du Cancer·Luca ArcainiMario Lazzarino
Jun 23, 2010·Cytometry. Part B, Clinical Cytometry·Roxana S DroncaClive S Zent
Apr 11, 2017·Journal of Internal Medicine·P GhiaF K Stevenson
Jan 11, 2017·Cytometry. Part B, Clinical Cytometry·Marc SorigueJavier Grau
Feb 25, 2018·Cytometry. Part B, Clinical Cytometry·Mariangeles AuatMaria Claudia Santos-Silva
Apr 3, 2008·American Journal of Hematology·Curtis A Hanson, William G Morice
Feb 14, 2020·Clinical and Experimental Medicine·Irene DefrancescoLuca Arcaini
Oct 28, 2016·World Journal of Gastroenterology : WJG·Michele MerliCarlo Visco

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.